Treatment involves supportive care and may include dialysis, steroids, blood transfusions, and plasmapheresis. While eculizumab is being used to treat atypical hemolytic uremic syndrome, no evidence as of 2018 supports its use in the main forms of HUS. Scientists are trying to understand how useful it would be to immunize humans or cattle.
complications of Shigellosis
complications of Cholera
complications of Campylobacteriosis
complications of Typhus
complications of Yellow fever
complications of Chagas disease
complications of Amoebiasis
complications of Lemierre's syndrome